Which medication, amiodarone or flecainide, lowers heart rate more?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amiodarone Lowers Heart Rate More Than Flecainide

Amiodarone is the clear choice for heart rate reduction, while flecainide has minimal to no effect on heart rate control. This is a fundamental pharmacologic difference between these two antiarrhythmic agents.

Key Pharmacologic Differences

Amiodarone's Rate-Lowering Effects

  • Amiodarone promptly reduces ventricular rate and maintains this effect for at least 8 hours, even in patients who do not successfully cardiovert to sinus rhythm 1
  • This rate control occurs through its multiple mechanisms of action, including beta-blocking properties and effects on AV nodal conduction
  • The 2024 ESC guidelines recognize amiodarone's utility when cardioversion is desired in patients with structural heart disease, accepting there may be a delay in cardioversion 2

Flecainide's Lack of Rate Control

  • Flecainide was no more effective than placebo in controlling ventricular rate in patients with atrial fibrillation 1
  • Flecainide primarily slows intracardiac conduction (particularly His-Purkinje system) but does not usually alter heart rate 3
  • The FDA label explicitly states that flecainide "does not usually alter heart rate, although bradycardia and tachycardia have been reported occasionally" 3

Clinical Context Matters

When Rate Control is the Priority

If your goal is heart rate reduction (not rhythm control):

  • Choose amiodarone for its reliable rate-lowering effects
  • Consider that amiodarone works even when cardioversion fails 1

Critical Safety Consideration with Flecainide

Flecainide can paradoxically INCREASE ventricular rate in atrial fibrillation/flutter by:

  • Slowing atrial rate and facilitating 1:1 AV conduction in atrial flutter 3
  • Creating a dangerous situation where ventricular response actually accelerates

The FDA label warns: "A paradoxical increase in the ventricular rate also may occur in patients with atrial fibrillation who receive flecainide acetate. Concomitant negative chronotropic therapy such as digoxin or beta-blockers may lower the risk of this complication" 3

Practical Algorithm

For heart rate control:

  1. Use amiodarone (not flecainide)
  2. If flecainide is used for rhythm control, always add AV nodal blocking agents (beta-blockers, calcium channel blockers, or digoxin) to prevent paradoxical rate acceleration

For rhythm control (cardioversion):

  • Flecainide is superior for rapid cardioversion (73% success at 8 hours vs 28% for amiodarone) 1, 4
  • But flecainide provides no rate control benefit

Bottom Line

These drugs serve different purposes: amiodarone for rate control, flecainide for rhythm control. If your question is specifically about which lowers heart rate more, amiodarone is unequivocally the answer.

References

Research

Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2021

Related Questions

Is methylphenidate safe to use in a patient with atrial fibrillation (AF) who is taking anti‑arrhythmic drugs?
What is the appropriate amiodarone regimen for converting and controlling atrial fibrillation, including dosing, monitoring, and alternative options?
In a hemodynamically stable patient with rapid‑ventricular‑response atrial fibrillation and no contraindications, what is the recommended repeat dosing regimen of intravenous amiodarone?
What are the best alternative antiarrhythmics for atrial fibrillation (AFib)?
What is the appropriate IV amiodarone loading and maintenance dosing protocol for a hemodynamically stable adult with new‑onset atrial fibrillation, and what monitoring is required?
After a cardiac arrest with up to 10 minutes of CPR, does hypoxic‑ischemic brain injury persist after return of spontaneous circulation and hospitalization, and what treatments (neuro‑protective measures, seizure control, intensive rehabilitation) are recommended after MRI shows structural damage weeks later to improve recovery or prevent further injury?
Can low-dose daily trimethoprim-sulfamethoxazole (Bactrim) used for urinary tract infection prophylaxis cause decreased kidney function?
In a 24-year-old woman who experiences severe nausea, shakiness, and dizziness lasting about 30 minutes after sexual intercourse, what are the possible differential diagnoses?
Can fluvoxamine (Luvox) and mirtazapine (Remeron) be used together for depression, and what are the recommended dosing and safety monitoring?
For typhoid fever, what is the recommended ceftriaxone dose and duration, and when can I step down to oral cefixine (cefexime) instead of completing a full 7‑day IV course?
What is the recommended evaluation and treatment for hard, lumpy (scybalous) stools?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.